MIM
MYOK

Monashee Investment Management’s MyoKardia, Inc. Common Stock MYOK Stock Holding History

Monashee Investment Management’s Portfolio MYOK Stock Details MYOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-120,000
Closed -$6.24M – 216
2019
Q1 		$6.24M Buy
+120,000
New +$5.53M 1.44% 18
2018
Q2 		– Sell
-12,000
Closed -$581K – 123
2018
Q1 		$586K Buy
+12,000
New +$624K 0.16% 92
2016
Q3 		– Hold
0
– – – 54

Other funds holding MYOK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Monashee Investment Management's MYOK Position: Q2 2019 in Review

Monashee Investment Management sold out of MyoKardia, Inc. Common Stock (MYOK) in Q2 2019, closing a stake of 120,000 shares — an estimated $6.24M sold.

Monashee Investment Management first reported a position in MYOK in Q1 2018 and held it in 2 quarters. The position peaked at $6.24M in Q1 2019. 155 funds tracked by Wall St. Rank hold MYOK as of Q2 2019.

  • Monashee Investment Management reported no remaining MyoKardia, Inc. Common Stock position as of Q2 2019 after selling out during the quarter.
  • Monashee Investment Management sold 120,000 MyoKardia, Inc. Common Stock shares in Q2 2019, an estimated $6.24M.
  • Monashee Investment Management first reported a position in MyoKardia, Inc. Common Stock in Q1 2018 and held it in 2 quarters.
  • Monashee Investment Management's MyoKardia, Inc. Common Stock position peaked at $6.24M in Q1 2019.
  • 155 funds tracked by Wall St. Rank held MyoKardia, Inc. Common Stock as of Q2 2019.

Based on Monashee Investment Management's 13F filing for Q2 2019, filed 7 Aug 2019.